Search Results
Apr 20, 2026, 02:57 ET AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026
improvements for patients with difficult-to-treat tumors."[212Pb]Pb-AG1002，SSTR2-targeted alpha therapyTitle: Preclinical evaluation of [212Pb]Pb-AG1002, a next generation SSTR2-targeting, non-agonist radiopharmaceuticalPoster
More news about: AlphaGen Therapeutics
Sep 29, 2025, 11:52 ET SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, BERY, PBPB on Behalf of Shareholders
multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-pgre-bery-pbpb-on-behalf-of-shareholders-302568894.html
More news about: Halper Sadeh LLP
Sep 16, 2025, 14:47 ET SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRY, PBPB, VMEO on Behalf of Shareholders
multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-bry-pbpb-vmeo-on-behalf-of-shareholders-302558046.html
More news about: Halper Sadeh LLP
Sep 15, 2025, 17:30 ET $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Potbelly Corporation (NASDAQ: PBPB)
PBPB) related to its sale to RaceTrac, Inc. Under the terms of the proposed transaction, Potbelly shareholders will receive $17.12
More news about: Monteverde & Associates PC
Sep 12, 2025, 10:43 ET SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PBPB, TRML, WAT on Behalf of Shareholders
multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-pbpb-trml-wat-on-behalf-of-shareholders-302555036.html
More news about: Halper Sadeh LLP